Tumour and plasma VEGF were both predictors for PFS (log-rank test, P=0.01 and 0.002, respectively) and RCC-SS (log-rank test, P=0.05 and 0.001, respectively; Figure 4C). This evidence concerns the gene VEGFA and synovial sarcoma.